SCHEMBL18001054

SCHEMBL18001054

CCCCCCCCc1ccc(C2(c3ccc(CCCCCCCC)cc3)c3cc(B4OC(C)(C)C(C)(C)O4)ccc3-c3ccc(B4OC(C)(C)C(C)(C)O4)cc32)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 9/20 0.67
LIPG Q9Y5X9 9/20 0.67
ESR1 P03372 2/20 0.36
ADRA2A P08913 2/20 0.36
ADORA3 P0DMS8 2/20 0.36
TACR2 P21452 2/20 0.36
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
SHBG P04278 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
HSPD1 P10809 1/20 0.36
ADRB3 P13945 1/20 0.36
HTR2C P28335 1/20 0.36
HSPE1 P61604 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2341239 1.00 LPL (0.67) LPLLIPGESR1ADRA2AADORA3
SCHEMBL14406710 0.96 LPL (0.62) LPLLIPGESR1ADRA2AADORA3
SCHEMBL18885445 0.96 LPL (0.62) LPLLIPGESR1ADRA2AADORA3
SCHEMBL10819558 0.94 LPL (0.60) LPLLIPGESR1ADRA2AADORA3
SCHEMBL14732224 0.94 LPL (0.60) LPLLIPGESR1ADRA2AADORA3
SCHEMBL13133443 0.94 LPL (0.60) LPLLIPGESR1ADRA2AADORA3
SCHEMBL16921378 0.94 LPL (0.59) LPLLIPGESR1ADRA2AADORA3
SCHEMBL20067408 0.91 LIPG (0.60) LPLLIPGSLC6A2SLC6A4CYP3A4
SCHEMBL9921514 0.91 LIPG (0.60) LPLLIPGSLC6A2SLC6A4CYP3A4
SCHEMBL11906223 0.87 LIPG (0.66) LPLLIPGGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10825991-B2 Composition and light emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-11-03 US disclosed
US-20170256726-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-09-07 US disclosed
US-20170200908-A1 METHOD OF PRODUCING LIGHT EMITTING DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-07-13 US disclosed
US-20170186959-A1 COMPOSITION AND LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-06-29 US disclosed
US-20170186959-A1 COMPOSITION AND LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-06-29 US disclosed
EP-3171673-A1 METHOD FOR MANUFACTURING LIGHT EMITTING ELEMENT Sumitomo Chemical Company Limited (JP) 2017-05-24 EP disclosed
EP-3093292-A1 METAL COMPLEX AND LIGHT EMITTING ELEMENT USING SAME Sumitomo Chemical Company, Limited (JP) 2016-11-16 EP disclosed
US-20160329508-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-11-10 US disclosed
US-20160233425-A1 LIGHT EMITTING DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170256726-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE USING THE SAME XPA, CRY1, SOD1 LPL 3460/4885LIPG 3979/4885ESR1 65/4885
US-20160329508-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE USING THE SAME NR2E3, SCO2, NR0B2 LPL 3781/4885LIPG 4373/4885ESR1 250/4885
US-20170200908-A1 METHOD OF PRODUCING LIGHT EMITTING DEVICE CDC5L, PPOX, NOX5 LPL 749/4885LIPG 1852/4885ESR1 915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.